By Business/Source
Currency:USD
2023/FY
Stock NameRevenueRatio
Business of developing and commercializing novel therapies for patients1.58M100.00%
By Country/Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States of America1.58M100.00%